Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

• Published in: Annals of oncology Vol. 35; no. 8; pp. 692 - 706
• Main Authors: Powles, T., Albiges, L., Bex, A., Comperat, E., Grünwald, V., Kanesvaran, R., Kitamura, H., McKay, R., Porta, C., Procopio, G., Schmidinger, M., Suarez, C., Teoh, J., de Velasco, G., Young, M., Gillessen, S.
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.08.2024
• Subjects: Carcinoma, Renal Cell - diagnosis; Carcinoma, Renal Cell - pathology; Carcinoma, Renal Cell - therapy; diagnosis; ESMO Clinical Practice Guideline (CPG); ESMO-MCBS; Europe - epidemiology; Follow-Up Studies; Humans; Kidney Neoplasms - diagnosis; Kidney Neoplasms - pathology; Kidney Neoplasms - therapy; management; Neoplasm Staging; renal cell carcinoma; treatment; Europe; treatment; diagnosis; renal cell carcinoma; ESMO-MCBS; ESMO Clinical Practice Guideline (CPG); management
• ISSN: 0923-7534; 1569-8041; 1569-8041
• DOI: 10.1016/j.annonc.2024.05.537

•This ESMO Clinical Practice Guideline provides key recommendations for managing renal cell carcinoma.•The guideline covers imaging and diagnosis, staging and risk assessment, treatment and follow-up.•Algorithms for the management of localised and advanced or metastatic disease are provided.•The authors comprise a multidisciplinary group of experts from different institutions and countries.•Recommendations are based on available scientific data and the authors’ collective expert opinion.